GFAP and thyroid gland disorder: Quantitative analysis of the immunofluorescence intensity showed that the NaIO3 treatment increased expression of GFAP by about 67%, compared with untreated controls, and treatment with anti-thyroid drug completely abolished the NaIO3-induced GFAP expression (Fig. 5).